Piramal Pharma Ltd. To Invest Minority Stake in Yapan Bio, India-Based CDMO Providing Expertise in Biologics and Vaccines
– Piramal Pharma Solutions adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering
– Investment of INR101.77cr in biologics reflects the company’s global commitment to this fast-growing segment of the pharma industry
